HGSI Financial Facts

Commercial collaboration expenses: 19.21M
Research and development collaborative agreements: 280K
See Full Income Statement

Cash and cash equivalents: 349.96M
Total current assets: 594.16M
See Full Balance Sheet

Human Genome Sciences Inc. (HGSI) Earnings

  |   Expand Research on HGSI
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate -8.4% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -11.6% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
4/24/12 Q112 -$0.47-$0.39 -$0.08$47.1M$45.94M N/A -3.6% Details
2/27/12 Q411 -$0.41-$0.43 +$0.02$45.5M$42.65M N/A +68.9% Details
10/25/11 Q311 -$0.45-$0.39 -$0.06$34M$37.31M N/A +13% Details
7/21/11 Q211 -$0.42-$0.41 -$0.01$24.9M$29.03M N/A -38.6% Details
4/28/11 Q111 -$0.69-$0.48 -$0.21$26.6M$19.26M N/A -51.9% Details
2/24/11 Q410 -$0.46-$0.38 -$0.08$21.3M$21.26M N/A -42.8% Details
10/27/10 Q310 -$0.22-$0.36 +$0.14N/AN/A N/A -46.4% Details